Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter

Use tags to find relevant records

3D printed implants

Ablation methods

Allogeneic mesenchymal stem cells

Ambulatory ECG monitoring

Aortic abdominal aneurysm

Aortic root replacement

Arthroplasty

Arthroscopy

Assisted ventilation

Atherectomy

Austria

Autologous chondrocyte implantation

Automated external defibrillator

AV fistula

AV graft

Balloon kyphoplasty

Bariatric surgery

Baroreflex activation therapy

Barrett’s oesophagus

Belgium

Benign prostatic hyperplasia

Biopsy

Bone Conductive Hearing Device

Breast reconstruction

Bronchial thermoplasty

Burns

Caesarean section

Cancer

Capsule endoscopy

Carbon ion therapy

Cardiac ablation

Cardiac computer tomography

Cardiac pacemaker

Cardiac resynchronization therapy

Cardiac Resynchronization Therapy Defibrillator (CRT-D)

Cardiovascular devices

Cardiovascular procedures

Carotid endarterectomy

Cataract

Cell therapy

Cesarean section

Cholecystectomy

Chronic obstructive pulmonary disease

Chronic wounds

Clinical guidelines

Cochlear implants

Commissioning

Companion diagnostic tests

Computed tomography

Conditional reimbursement

Connected medical devices

Continuous glucose monitoring (CGM)

Coronary interventions

Coronary percutaneous revascularization procedures

Coronary procedures

Coronavirus

Benign prostatic hyperplasia

09

Sep 2020

EUnetHTA published a project plan for the comparative effectiveness of surgical techniques and devices for the treatment of benign prostate hyperplasia

At the end of July 2020, the network of European HTA agencies, EUnetHTA, announced the final plan of the project OTCA27 “Comparative effectiveness of surgical techniques and devices for the treatment of benign prostatic hyperplasia (BPH).”